))
On The Pen: The Weekly Dose 6.4.24
Manage episode 421956642 series 3550124
Content provided by Dave Knapp Man On The Mounjaro. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dave Knapp Man On The Mounjaro or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
https://ro.co/weight-loss/supply-tracker
https://www.youtube.com/watch?v=mL_krAas70k
Novo Nordisk Advertising:
- Novo Nordisk launches new advertising campaign "The Power of Wegovy"
- This advertisement includes the new indication for reduction of cardiovascular risk
- For 2023, the #5 advertising spend for a drug was Rybelsus at $191 million. The #6 advertising spend was Ozempic at $187.4 million (increase of 6% from 2022). More than 40% of the 2023 ad spend for Ozempic went to online video platforms (i.e. social media like youtube)
- Link: https://www.youtube.com/watch?v=dhretLXYkZ4
Structure Therapeutics GSBR-1290
- GSBR-1290 is a small molecule GLP-1 pill
- In a 12-week phase 2 clinical study, a tablet formulation of GSBR-1290 had a weight-loss of 6.9%. This is comparable to Eli Lilly's phase 2 results for olforglipron
- At Week 12, 67% of GSBR-1290 treated participants achieved ≥6% weight loss and 33% achieved ≥ 10% weight loss, compared to 0% for placebo
- Also developing next generation combination GLP-1 candidates together with GIP, amylin, glucagon and apelin oral small molecules
- Link (Madison Muller): https://www.bloomberg.com/news/articles/2024-06-03/structure-reports-early-oral-weight-loss-drug-data-adding-allure
Elon musk tweet:
- Elon Musk tweeted: Just make a lot of Ozempic/Mounjaro. It’s not inherently expensive. The health benefits of reducing obesity far exceed the downside of GLP-1 inhibitors. We evolved under starving conditions and now make food that is plentiful and delicious. Whether that food is “processed” does matter, but is not a game changer
- This tweet has currently been seen 325,500 times
Shanghai Stem Cell Type 2 Diabetes Treatment
https://www.scmp.com/news/china/science/article/3263878/chinese-scientists-report-world-first-they-cure-patients-diabetes-cell-therapy
Support the Show.
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
Venmo: OnThePen
Ca$h App: ManOnMounjaro
BECOME A MEMBER:
https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
SOCIAL LINKS
https://www.tiktok.com/@manonthemounjaro
https://twitter.com/ManOnMounjaro
https://instagram.com/manonthemounjaro
https://facebook.com/manonthemounjaro
📲 Contact Me: MounjaroMan@gmail.com
📼 PLAYLISTS:
🖊️ ON THE PEN LIVES:
https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM
👀 WATCH MY MOUNJARO JOURNEY IN ORDER:
https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO
😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:
https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW
🚨📰 ALL THE LATEST MOUNJARO NEWS:
https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com.
40 episodes
Share
